Millions of people around the world have received two shots of Sinovac, a Chinese-manufactured inactive vaccine that is used in 48 countries to help reduce transmission rates of COVID-19.
Jan 20, 2022
0
225
Prior infection with coronaviruses that cause the common cold impedes the antibody immune response against SARS-CoV-2, the coronavirus responsible for COVID-19. The results from St. Jude Children's Research Hospital appeared ...
Jan 13, 2022
0
373
New research shows that the first SARS-CoV-2 spike protein a person encounters, be it by vaccination or infection, shapes their subsequent immune response against current and future variants. That is, it imparts different ...
Dec 2, 2021
0
395
With the emergence of SARS-CoV-2 variants worldwide, the pandemic's spread is accelerating. A research team led by Joelle Pelletier and Jean-François Masson, both professors in Université de Montréal's Department of Chemistry, ...
Nov 8, 2021
0
624
In what is believed to be one of the largest studies of its kind, Johns Hopkins Medicine researchers have shown that antibody levels against SARS-CoV-2 (the COVID-19 virus) stay more durable—that is, remain higher over ...
Nov 1, 2021
2
233
New research from the University of Virginia School of Medicine quantifies the antibody response generated by the Pfizer and Moderna COVID vaccines. The findings are some of the earliest to compare the two vaccines' antibody ...
Sep 2, 2021
0
290
Total antibody levels appear to start declining from as early as six weeks after complete vaccination and can reduce by more than 50% over 10 weeks, according to new data from UCL's Virus Watch study.
Jul 26, 2021
2
1807
Testing of an entire Italian town shows antibody levels remain high nine months after SARS-CoV-2 infection, whether symptomatic or asymptomatic.
Jul 19, 2021
0
345
A McMaster University team of researchers recently discovered how, exactly, the COVID-19 vaccines that use adenovirus vectors trigger a rare but sometimes fatal blood clotting reaction called vaccine-induced immune thrombotic ...
Jul 7, 2021
0
171
Researchers from the University of Oxford have today released their findings about the so-called 'correlates of protection' against symptomatic COVID-19; potentially a tool to speed up safe development of new vaccines which ...
Jun 28, 2021
0
16
